News Summary

Alphabet has significantly reduced its involvement in Verily, its life sciences business, as Verily undergoes restructuring. The company announced a $300 million investment round and plans to transform from an LLC to a corporation, renaming itself Verily Health Inc. This change means Alphabet now holds a minority stake in the venture. Verily is shifting its focus towards AI-driven healthcare solutions, aiming to merge clinical and scientific rigor with AI to advance precision and personalized healthcare. The restructuring includes a strategic pivot following the closure of its medical device division.